keyword
https://read.qxmd.com/read/38664685/electrical-impedance-tomography-as-a-monitoring-tool-during-weaning-from-mechanical-ventilation-an-observational-study-during-the-spontaneous-breathing-trial
#41
JOURNAL ARTICLE
Jantine J Wisse, Tom G Goos, Annemijn H Jonkman, Peter Somhorst, Irwin K M Reiss, Henrik Endeman, Diederik Gommers
BACKGROUND: Prolonged weaning from mechanical ventilation is associated with poor clinical outcome. Therefore, choosing the right moment for weaning and extubation is essential. Electrical Impedance Tomography (EIT) is a promising innovative lung monitoring technique, but its role in supporting weaning decisions is yet uncertain. We aimed to evaluate physiological trends during a T-piece spontaneous breathing trail (SBT) as measured with EIT and the relation between EIT parameters and SBT success or failure...
April 25, 2024: Respiratory Research
https://read.qxmd.com/read/38664423/a-real-world-pharmacovigilance-study-of-amivantamab-related-cardiovascular-adverse-events-based-on-the-fda-adverse-event-reporting-system-faers-database
#42
JOURNAL ARTICLE
Rui Sun, Zhen Ning, Henan Qin, Wenhe Zhang, Yibin Teng, Chenxing Jin, Jiwei Liu, Aman Wang
Amivantamab is the first dual-specificity antibody targeting EGFR and MET, which is approved for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) with EGFR exon 20 insertion mutations. Cardiovascular toxicities related to amivantamab have not been reported in the CHRYSALIS study. However, the occurrence of cardiovascular events in the real world is unknown. To comprehensively investigate the clinical characteristics, onset times, and outcomes of cardiovascular toxicities associated with amivantamab...
April 25, 2024: Scientific Reports
https://read.qxmd.com/read/38663888/lung-volume-measurement-using-chest-ct-in-covid-19-patients-a-cohort-study-in-japan
#43
MULTICENTER STUDY
Shiro Otake, Yusuke Shiraishi, Shotaro Chubachi, Naoya Tanabe, Tomoki Maetani, Takanori Asakura, Ho Namkoong, Takashi Shimada, Shuhei Azekawa, Kensuke Nakagawara, Hiromu Tanaka, Takahiro Fukushima, Mayuko Watase, Hideki Terai, Mamoru Sasaki, Soichiro Ueda, Yukari Kato, Norihiro Harada, Shoji Suzuki, Shuichi Yoshida, Hiroki Tateno, Yoshitake Yamada, Masahiro Jinzaki, Toyohiro Hirai, Yukinori Okada, Ryuji Koike, Makoto Ishii, Naoki Hasegawa, Akinori Kimura, Seiya Imoto, Satoru Miyano, Seishi Ogawa, Takanori Kanai, Koichi Fukunaga
OBJECTIVE: This study aimed to investigate the utility of CT quantification of lung volume for predicting critical outcomes in COVID-19 patients. METHODS: This retrospective cohort study included 1200 hospitalised patients with COVID-19 from 4 hospitals. Lung fields were extracted using artificial intelligence-based segmentation, and the percentage of the predicted (%pred) total lung volume (TLC (%pred)) was calculated. The incidence of critical outcomes and posthospitalisation complications was compared between patients with low and high CT lung volumes classified based on the median percentage of predicted TLCct (n=600 for each)...
April 24, 2024: BMJ Open Respiratory Research
https://read.qxmd.com/read/38663582/patient-reported-outcomes-after-personalised-dose-escalation-for-stage-ii-iii-non-small-cell-lung-cancer-patients-results-from-the-randomised-artforce-pet-boost-trial
#44
JOURNAL ARTICLE
Saskia A Cooke, José S A Belderbos, Bart Reymen, Maarten Lambrecht, Gitte Fredberg Persson, Corinne Faivre-Finn, Edith M T Dieleman, Judi N A van Diessen, Jan-Jakob Sonke, Dirk de Ruysscher
BACKGROUND AND PURPOSE: The ultimate challenge in dose-escalation trials lies in finding the balance between benefit and toxicity. We examined patient-reported outcomes (PROs), including health-related quality of life (HRQoL) in patients with locally advanced non-small cell lung cancer (LA-NSCLC), treated with dose-escalated radiotherapy. MATERIALS AND METHODS: The international, randomised, phase 2 ARTFORCE PET-Boost study (NCT01024829) aimed to improve 1-year freedom from local failure rates in patients with stage II-III NSCLC, with a ≥ 4 cm primary tumour...
April 23, 2024: Radiotherapy and Oncology
https://read.qxmd.com/read/38662569/inspiratory-muscle-training-in-patients-living-with-chronic-kidney-disease-and-receiving-hemodialysis-meta-analysis-of-randomized-controlled-trials
#45
JOURNAL ARTICLE
Ana Karla Vieira Brüggemann, Jociane Schardong, Natiele Camponogara Righi, Rodrigo Della Méa Plentz
OBJECTIVE: People living with chronic kidney disease (CKD) and receiving hemodialysis (HD) have impaired respiratory muscle strength and endurance. The objective of this study was to systematically review the effects of inspiratory muscle training (IMT) on respiratory muscle strength, functional capacity, lung function, quality of life, endothelial function, and oxidative stress in people living with CKD and receiving HD. METHODS: An electronic search was conducted from inception to June 2023...
April 25, 2024: Physical Therapy
https://read.qxmd.com/read/38662371/deployment-to-military-bases-with-open-burn-pits-and-respiratory-and-cardiovascular-disease
#46
JOURNAL ARTICLE
David A Savitz, Susan R Woskie, Anila Bello, Rachel Gaither, Joseph Gasper, Lan Jiang, Christopher Rennix, Gregory A Wellenius, Amal N Trivedi
IMPORTANCE: Many veterans who served in Afghanistan and Iraq during Operations Enduring Freedom (OEF) and Operation Iraqi Freedom (OIF) were deployed to military bases with open burn pits and exposed to their emissions, with limited understanding of the long-term health consequences. OBJECTIVE: To determine the association between deployment to military bases where open burn pits were used for waste disposal and the subsequent risk of developing respiratory and cardiovascular diseases...
April 1, 2024: JAMA Network Open
https://read.qxmd.com/read/38660953/effects-of-a-pulmonary-rehabilitation-program-on-pulmonary-function-exercise-performance-and-quality-of-life-in-patients-with-severe-covid-19
#47
JOURNAL ARTICLE
María Fernanda Del Valle, Jorge Valenzuela, Claudio Bascour-Sandoval, Gabriel Nasri Marzuca-Nassr, Mariano Del Sol, Constanza Díaz Canales, Máximo Escobar-Cabello, Rodrigo Lizama-Pérez, Fernando Valenzuela-Aedo, Rodrigo Muñoz-Cofré
BACKGROUND: Severe coronavirus 2019 disease (COVID-19) causes acute hypoxemic respiratory failure requiring invasive mechanical ventilation (IMV). Once these symptoms are resolved, patients can present systemic deterioration. OBJECTIVE: The two objectives of this study were as follows: to describe the results of a pulmonary rehabilitation program (PRP), which is divided into three groups with different numbers of sessions (12, 24, and 36), and to associate the variables of pulmonary function, exercise performance, and functionality with the number of sessions and functional improvement...
2024: Therapeutic Advances in Respiratory Disease
https://read.qxmd.com/read/38660779/the-role-of-chest-x-ray-in-the-diagnosis-of-neonatal-respiratory-distress-syndrome-a-systematic-review-concerning-low-resource-birth-scenarios
#48
REVIEW
Gabriela Silveira Neves, Zilma Silveira Nogueira Reis, Roberta Maia de Castro Romanelli, Jannine Dos Santos Nascimento, André Dias Sanglard, James Batchelor
BACKGROUND: Access to diagnostic tools like chest radiography (CXR) is challenging in resource-limited areas. Despite reduced reliance on CXR due to the need for quick clinical decisions, its usage remains prevalent in the approach to neonatal respiratory distress syndrome (NRDS). OBJECTIVES: To assess CXR's role in diagnosing and grading NRDS severity compared to current clinical features and laboratory standards. METHODS: A review of studies with NRDS diagnostic criteria was conducted across six databases (MEDLINE, EMBASE, BVS, Scopus-Elsevier, Web of Science, Cochrane) up to 3 March 2023...
December 31, 2024: Global Health Action
https://read.qxmd.com/read/38660321/anomalous-systemic-arterial-supply-to-the-basal-segment-of-the-lung-presenting-with-haemoptysis-in-the-third-trimester-of-pregnancy
#49
JOURNAL ARTICLE
Kate Hawke, Kaustuv Joshi, Hervey Lau, Arani Halder, Petrina Duncan, Penny Wolski
Anomalous systemic arterial supply to the basal segment of the lung (ABLL) is a rare cause of haemoptysis. ABLL may be complicated by massive haemoptysis, heart failure due to left-to-right shunt and infection. We describe a case of this condition presenting in the third trimester of pregnancy. Computed tomography chest angiogram confirmed the diagnosis. A multidisciplinary approach was necessary to determine treatment, which ultimately consisted of elective caesarean section at 36 weeks and 4 days' gestation, followed by transarterial embolisation 9 days postpartum...
March 2024: Obstetric Medicine
https://read.qxmd.com/read/38659139/factors-associated-with-referrals-for-directly-observed-treatment-and-unsuccessful-treatment
#50
MULTICENTER STUDY
Y D González Diaz, D Palma, H Vargas-Leguás, T Rodrigo, I Molina-Pinargorte, X Casas, N Forcada, J Santiago, N Altet, J-P Millet
<sec id="st1"><title>OBJECTIVE</title>To describe the characteristics of people indicated for directly observed treatment (DOT) in Spain, and the factors associated with unsuccessful treatment.</sec><sec id="st2"><title>METHODS</title>This was a multicentre observational study based on a prospective follow-up of patients over 18 years old diagnosed with TB between 2006 and 2019 from the registry of the Programa Integrado de Investigación en Tuberculosis (PII-TB)...
May 1, 2024: International Journal of Tuberculosis and Lung Disease
https://read.qxmd.com/read/38658913/a-case-of-hypercalcemia-from-pneumocystis-jirovecii-in-an-immunosuppressed-non-hiv-patient
#51
JOURNAL ARTICLE
Vishrut Gulhati, Janeve Desy, Christina S Thornton
BACKGROUND: The prevalence of non-HIV related Pneumocystis jirovecii pneumonia (PJP) is increasing with use of immunosuppressive therapies. There are case reports of solid organ transplant recipients on immunosuppressive therapy presenting with mild hypercalcemia, leading to a diagnosis of PJP. Recent studies have shown efficacy of PJP prophylaxis for patients treated with rituximab with a favourable adverse effect profile. CASE PRESENTATION: A 78-year-old male with a history of PR3-ANCA vasculitis, chronic kidney disease and heart failure with reduced ejection fraction presented to our tertiary care hospital with a two-week history of confusion and non-productive cough...
April 24, 2024: BMC Pulmonary Medicine
https://read.qxmd.com/read/38658500/association-between-interstitial-lung-abnormality-and-mortality-in-patients-with-esophageal-cancer
#52
JOURNAL ARTICLE
Akinori Hata, Masahiro Yanagawa, Tomo Miyata, Yu Hiraoka, Motohiro Shirae, Keisuke Ninomiya, Shuhei Doi, Kazuki Yamagata, Yuriko Yoshida, Noriko Kikuchi, Ryo Ogawa, Hiroto Hatabu, Noriyuki Tomiyama
PURPOSE: To investigate the relationship between interstitial lung abnormalities (ILAs) and mortality in patients with esophageal cancer and the cause of mortality. MATERIALS AND METHODS: This retrospective study investigated patients with esophageal cancer from January 2011 to December 2015. ILAs were visually scored on baseline CT using a 3-point scale (0 = non-ILA, 1 = indeterminate for ILA, and 2 = ILA). ILAs were classified into subcategories of non-subpleural, subpleural non-fibrotic, and subpleural fibrotic...
April 25, 2024: Japanese Journal of Radiology
https://read.qxmd.com/read/38657776/cd8-t-cell-mediated-rejection-of-allogenic-human-induced-pluripotent-stem-cell-derived-cardiomyocyte-sheets-in-human-pbmc-transferred-nog-mhc-double-knockout-mice
#53
JOURNAL ARTICLE
Ryu Matsumoto, Yin Enzhi, Kazuyoshi Takeda, Kodai Morimoto, Kyoko Yogo, Masaki Harada, Koji Tokushige, Yui Maehara, Saori Hirota, Yuko Kojima, Mamoru Ito, Nagako Sougawa, Shigeru Miyagawa, Yoshiki Sawa, Ko Okumura, Koichiro Uchida
BACKGROUND: Transplantation of human induced pluripotent stem cell-derived cardiomyocytes (hiPS-CMs) has emerged as a promising therapy to treat end-stage heart failure. However, immunogenicity of hiPS-CMs in transplanted patients has not been fully elucidated. Thus, in vivo models are required to estimate immune responses against hiPS-CMs in transplant recipients. METHODS: We transferred human peripheral blood mononuclear cells (hPBMCs) into NOD/Shi-scid IL2rgnull (NOG) MHC class I/II double knockout (NOG-ΔMHC) mice, which were reported to accept hPBMCs without xenogeneic-graft-versus-host disease (xeno-GVHD)...
April 22, 2024: Journal of Heart and Lung Transplantation
https://read.qxmd.com/read/38657024/inhibiting-eph-ephrin-signaling-reduces-vascular-leak-and-endothelial-cell-dysfunction-in-mice-with-sepsis
#54
JOURNAL ARTICLE
Nemat Khan, Vinod Kumar, Pengcheng Li, Luregn J Schlapbach, Andrew W Boyd, Mark G Coulthard, Trent M Woodruff
Sepsis is a life-threatening disease caused by a dysregulated host response to infection, resulting in 11 million deaths globally each year. Vascular endothelial cell dysfunction results in the loss of endothelial barrier integrity, which contributes to sepsis-induced multiple organ failure and mortality. Erythropoietin-producing hepatocellular carcinoma (Eph) receptors and their ephrin ligands play a key role in vascular endothelial barrier disruption but are currently not a therapeutic target in sepsis. Using a cecal ligation and puncture (CLP) mouse model of sepsis, we showed that prophylactic or therapeutic treatment of mice with EphA4-Fc, a decoy receptor and pan-ephrin inhibitor, resulted in improved survival and a reduction in vascular leak, lung injury, and endothelial cell dysfunction...
April 24, 2024: Science Translational Medicine
https://read.qxmd.com/read/38656126/increased-virtual-visits-to-physicians-during-the-covid-19-pandemic-and-estimated-impact-on-physician-compensation-the-case-of-lung-and-colorectal-cancers-chronic-obstructive-pulmonary-diseases-and-heart-failure-in-alberta-canada
#55
JOURNAL ARTICLE
Nguyen Xuan Thanh, Arianna Waye, Douglas Stewart, Jason Weatherald, Grace Y Lam, Michael K Stickland, Michael D Hill, Jonathan Choy, Anderson W Chuck, Tracy Wasylak
Introduction: The COVID-19 pandemic started in Alberta in March 2020 and significantly increased telehealth service use and provision reducing the risk of virus transmission. We examined the change in the number and proportion of virtual visits by physician specialty and condition (chronic obstructive pulmonary diseases [COPD], heart failure [HF], colorectal and lung cancers), as well as associated changes in physician compensation. Methods: A population-based design was used to analyze all processed physician claims comparing the number and proportion of virtual visits and associated physician billings relative to in-person between pre- (2019/2020) and intra-pandemic (2020/2021)...
April 24, 2024: Telemedicine Journal and E-health
https://read.qxmd.com/read/38655831/-workplace-associated-fever
#56
REVIEW
Celine Schumacher, Christian Clarenbach, Holger Dressel
Febrile conditions often have an infectious etiology. However, there are also fevers associated with occupational exposures. A detailed occupational history can hold the key to the diagnosis. In the case of exposure to organic dusts, the development of hypersensitivity pneumonitis (HP) is possible. Thus, HP should be considered in the presence of interstitial lung disease of unclear etiology. Failure to recognize this can have dramatic consequences and, in extreme cases, lead to lung transplantation. Differentially, organic dust toxic syndrome (ODTS) must be considered...
February 2024: Therapeutische Umschau. Revue Thérapeutique
https://read.qxmd.com/read/38655005/early-identification-of-sox17-deficiency-in-infants-to-guide-management-of-heritable-pulmonary-arterial-hypertension-using-pda-stent-to-create-reverse-potts-shunt-physiology
#57
Heidi Ostler, Carolyn Fall, Howaida El-Said, Henri Justino, Shylah Haldeman, Jeanne Carroll, Rohit Rao
Heritable pulmonary arterial hypertension (HPAH) is a rare progressive condition that includes patients with an identified genetic cause of pulmonary arterial hypertension (PAH). HPAH and idiopathic PAH (IPAH) have an estimated combined incidence of 0.5-0.9 cases per million children-years. Several pathogenic variants have been associated with HPAH in children and adults, including genes BMPR2 , TBX4 , and  ACVRL1 , and more rarely with variants in genes such as SOX17 . HPAH is often difficult to manage and has poor prognosis despite advances in medical therapy with many patients progressing to lung transplantation, right heart failure and death...
April 2024: Pulmonary Circulation
https://read.qxmd.com/read/38654351/case-study-observational-research-inflammatory-cytokines-in-the-bronchial-epithelial-lining-fluid-of-covid-19-patients-with-acute-hypoxemic-respiratory-failure
#58
JOURNAL ARTICLE
Kazuki Sudo, Mao Kinoshita, Ken Kawaguchi, Kohsuke Kushimoto, Ryogo Yoshii, Keita Inoue, Masaki Yamasaki, Tasuku Matsuyama, Kunihiko Kooguchi, Yasuo Takashima, Masami Tanaka, Kazumichi Matsumoto, Kei Tashiro, Tohru Inaba, Bon Ohta, Teiji Sawa
BACKGROUND: In this study, the concentrations of inflammatory cytokines were measured in the bronchial epithelial lining fluid (ELF) and plasma in patients with acute hypoxemic respiratory failure (AHRF) secondary to severe coronavirus disease 2019 (COVID-19). METHODS: We comprehensively analyzed the concentrations of 25 cytokines in the ELF and plasma of 27 COVID-19 AHRF patients. ELF was collected using the bronchial microsampling method through an endotracheal tube just after patients were intubated for mechanical ventilation...
April 23, 2024: Critical Care: the Official Journal of the Critical Care Forum
https://read.qxmd.com/read/38653004/non-pharmacological-interventions-to-reduce-thirst-in-patients-with-heart-failure-or-hemodialysis-a-systematic-review-and-meta-analysis
#59
REVIEW
Franziska Wefer, Lars Krüger, Nana Waldréus, Sascha Köpke
BACKGROUND: Thirst is a frequent and burdening symptom in many patients, especially in patients with chronic heart failure (CHF) and/or receiving hemodialysis (HD). As drug therapies are not feasible, non-pharmacological strategies are needed to reduce thirst and thirst-related burden. OBJECTIVES: To identify non-pharmacological interventions aiming to reduce thirst in patients with CHF and/ or HD, to describe intervention components, and to evaluate the effectiveness of these interventions...
April 22, 2024: Heart & Lung: the Journal of Critical Care
https://read.qxmd.com/read/38651896/mucus-polymer-concentration-and-in-vivo-adaptation-converge-to-define-the-antibiotic-response-of-pseudomonas-aeruginosa-during-chronic-lung-infection
#60
JOURNAL ARTICLE
Matthew A Greenwald, Suzanne L Meinig, Lucas M Plott, Cristian Roca, Matthew G Higgs, Nicholas P Vitko, Matthew R Markovetz, Kaitlyn R Rouillard, Jerome Carpenter, Mehmet Kesimer, David B Hill, Jonathan C Schisler, Matthew C Wolfgang
UNLABELLED: The airway milieu of individuals with muco-obstructive airway diseases (MADs) is defined by the accumulation of dehydrated mucus due to hyperabsorption of airway surface liquid and defective mucociliary clearance. Pathological mucus becomes progressively more viscous with age and disease severity due to the concentration and overproduction of mucin and accumulation of host-derived extracellular DNA (eDNA). Respiratory mucus of MADs provides a niche for recurrent and persistent colonization by respiratory pathogens, including Pseudomonas aeruginosa , which is responsible for the majority of morbidity and mortality in MADs...
April 23, 2024: MBio
keyword
keyword
170943
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.